Gianfranco Pittari, MD PhD, currently serves as Chief Medical Officer at MaaT Pharma, a role assumed in June 2024. Previously, Gianfranco held positions including Executive Medical Director for Clinical Development at Autolus Ltd. and Director of Senior Clinical Trial Physician at Celgene, Bristol Myers Squibb. With extensive experience in clinical development focusing on CAR T cell strategies for multiple myeloma, Gianfranco has also worked as Senior Consultant in Hematology BMT at Hamad Medical Corporation in Qatar and as a Research Fellow at Memorial Sloan-Kettering Cancer Center. Educational credentials include a Doctor of Medicine from Università di Pavia, a PhD in Immunology from Paris-Sud University, and a European Diploma for Clinical Research in Oncology.
This person is not in the org chart